Literature DB >> 26621644

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.

Barry J Maron, James E Udelson, Robert O Bonow, Rick A Nishimura, Michael J Ackerman, N A Mark Estes, Leslie T Cooper, Mark S Link, Martin S Maron.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death

Mesh:

Year:  2015        PMID: 26621644     DOI: 10.1161/CIR.0000000000000239

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  87 in total

Review 1.  Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Authors:  Gabriela M Orgeron; Hugh Calkins
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

2.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

3.  A case of fulminant myocarditis treated with very long-term support by cardiopulmonary support system.

Authors:  Takahiro Mito; Masao Takemoto; Yuki Kawano; Atsushi Tanaka; Atsutoshi Matsuo; Satoru Hida; Hiroyuki Saisyo; Kouichiro Shimoishi; Hidetsugu Hori; Teiji Okazaki; Kei-Ichiro Tayama; Kiyonobu Yoshitake; Kenichi Kosuga
Journal:  J Cardiol Cases       Date:  2016-08-06

4.  Clinical and magnetic resonance evolution of "infarct-like" myocarditis.

Authors:  Riccardo Faletti; Marco Gatti; Ilaria Baralis; Laura Bergamasco; Rodolfo Bonamini; Francesca Ferroni; Massimo Imazio; Silvia Stola; Fiorenzo Gaita; Paolo Fonio
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

Review 5.  Lamin A/C Cardiomyopathy: Implications for Treatment.

Authors:  Suet Nee Chen; Orfeo Sbaizero; Matthew R G Taylor; Luisa Mestroni
Journal:  Curr Cardiol Rep       Date:  2019-11-26       Impact factor: 2.931

Review 6.  Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies.

Authors:  Kia Afshar; T Jared Bunch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

Review 7.  Recommendations for exercise and screening for safe athletic participation in hypertensive youth.

Authors:  Carissa M Baker-Smith; Nicholas Pietris; Laide Jinadu
Journal:  Pediatr Nephrol       Date:  2019-04-26       Impact factor: 3.714

Review 8.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 9.  Hypertrophic Cardiomyopathy in Athletes.

Authors:  Aneil Malhotra; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2017-12

Review 10.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.